glp-1 drugs and crohn's disease Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, therapeutic potential Mapping the effectiveness and risks

Name: glp-1 drugs and crohn's disease Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, therapeutic potential Mapping the effectiveness and risks
Brand: businesscommunicationnetwork.com
SKU: 42566820543
Price: 27.29 USD
Availability: InStock
Rating: 4.369 (19 reviews)

SKU: 42566820543

4.4

SEK27.29 SEK72.29

Pay in 4 interest-free payments of $6.82 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Live Spec

Mapping the effectiveness and risks of GLP 1 receptor agonists Nature Medicine Role of glucagon like peptides in inflammatory bowel diseasescurrent knowledge and future perspectives Naunyn Schmiedeberg's Archives of Pharmacology Springer Nature Link Weight Loss Medications & IBD Mochi Health Adjunctive GLP1 Receptor Agonists in Patients With Inflammatory Bowel Diseases and Obesity and or Diabetes: A Target Trial Emulation ScienceDirect GLP 1 Use in Crohn's Disease: Safety & IBD Considerations PlexusDx Relevance of Glucagon Like Peptide 1 (GLP 1) in Inflammatory Bowel Diseases: A Narrative Review

Store: businesscommunicationnetwork.com · Domain: businesscommunicationnetwork.com

Description

Remodeling the tumor microenvironment with core-shell nanosensitizer featuring dual-modal imaging and multimodal therapy for breast cancer